Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.

about

The Low-Dose (7.5 mg/day) Pioglitazone Therapy.Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats.

P2860

Q41353986-7F2F0FB4-A9B1-4912-8C74-228C1E3CB643 Q51283845-E3B20D6B-ED66-4E08-ACA8-67768005C761

P2860

Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.

Item

http://www.wikidata.org/entity/Q47901833

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@en

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@nl

type

Item

label

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@en

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@nl

prefLabel

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@en

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@nl

P1476

Pharmacodynamic Effects of Low ...... ome without Diabetes Mellitus.

@en

P2093

Amber L Beitelshees

http://www.w3.org/2001/XMLSchema#string

Anh Vu

http://www.w3.org/2001/XMLSchema#string

Brooke Bredbeck

http://www.w3.org/2001/XMLSchema#string

Christina L Aquilante

http://www.w3.org/2001/XMLSchema#string

Julie Predhomme

http://www.w3.org/2001/XMLSchema#string

Kimberly M Deininger

http://www.w3.org/2001/XMLSchema#string

Lisa A Kosmiski

http://www.w3.org/2001/XMLSchema#string

Maha S Sidhom

http://www.w3.org/2001/XMLSchema#string

Ronald Prigeon

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication

Type 2 diabetes can be prevented with early pharmacological intervention

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

The metabolic syndrome--a new worldwide definition

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Omentin: a novel link between inflammation, diabesity, and cardiovascular disease.

The metabolic syndrome

P304

252-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1713

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26822630

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.

about

P2860

P2860

Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921